{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:41:01Z","timestamp":1790862061889,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejvs.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T01:31:40Z","timestamp":1759627900000},"page":"647-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Endovascular Treatment for Calcified Femoropopliteal Peripheral Artery Disease and Risk Factor Identification: Two Year Outcomes of the Evolusion Study"],"prefix":"10.1016","volume":"71","author":[{"given":"Bing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-9733","authenticated-orcid":false,"given":"Ziheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2025.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae114","article-title":"New horizons in peripheral artery disease","volume":"53","author":"Houghton","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejvs.2025.10.002_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1S","key":"10.1016\/j.ejvs.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.10.002_bib5","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40265-022-01755-7","article-title":"Current management of peripheral artery disease: focus on pharmacotherapy","volume":"82","author":"Golledge","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.ejvs.2025.10.002_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/17434440.2020.1770593","article-title":"Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis","volume":"17","author":"Anantha-Narayanan","year":"2020","journal-title":"Expert Rev Med Devices"},{"issue":"Suppl. 2","key":"10.1016\/j.ejvs.2025.10.002_bib8","doi-asserted-by":"crossref","first-page":"II30","DOI":"10.1177\/15266028060130S207","article-title":"Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries","volume":"13","author":"Laird","year":"2006","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2025.10.002_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2025.10.002_bib10","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehae372","article-title":"Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial","volume":"45","author":"Ko","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2025.10.002_bib11","first-page":"910","article-title":"Feasibility and 1-year outcomes of subintimal revascularization with Supera\u00ae stenting of long femoropopliteal occlusions in critical limb ischemia: the \u201cSupersub\u201d study","volume":"89","author":"Palena","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/CIRCULATIONAHA.111.036574","article-title":"Percutaneous treatment of peripheral artery disease: novel techniques","volume":"126","author":"Schillinger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.10.002_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1583\/JEVT-12-3815MR.1","article-title":"Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial","volume":"19","author":"Shammas","year":"2012","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2025.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025677","article-title":"Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion","volume":"12","author":"Soga","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2025.10.002_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/15266028221134891","article-title":"Standard balloon angioplasty versus Serranator serration balloon angioplasty for the treatment of below-the-knee artery occlusive disease: a single-center subanalysis from the PRELUDE-BTK prospective study","volume":"31","author":"Guetl","year":"2024","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.ejvs.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jcin.2021.04.010","article-title":"Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the randomized disrupt PAD III trial","volume":"14","author":"Tepe","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2025.10.002_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2305637","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","volume":"390","author":"Varcoe","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2025.10.002_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib19","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1161\/CIRCULATIONAHA.105.546507","article-title":"Ethnicity and peripheral arterial disease: the San Diego Population Study","volume":"112","author":"Criqui","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.10.002_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2458-10-38","article-title":"The peripheral arterial disease study (PERART\/ARTPER): prevalence and risk factors in the general population","volume":"10","author":"Alzamora","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ejvs.2025.10.002_bib21","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010601","article-title":"National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis","volume":"9","author":"Song","year":"2019","journal-title":"J Glob Health"},{"key":"10.1016\/j.ejvs.2025.10.002_bib22","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(17)30819-X","article-title":"Smoking prevalence and attributable disease burden in 195 countries and territories, 1990\u20132015: a systematic analysis from the Global Burden of Disease study 2015","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2025.10.002_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejvs.2023.07.020","article-title":"Editor\u2019s Choice \u2013 The Intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer","volume":"66","author":"Fitridge","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007462","article-title":"Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States","volume":"7","author":"Lu","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2025.10.002_bib26","first-page":"E212","article-title":"Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications","volume":"83","author":"Rocha-Singh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2025.10.002_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejvs.2008.06.020","article-title":"Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions","volume":"36","author":"Diehm","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.ejvs.2025.10.002_bib30","first-page":"1884","article-title":"A systematic review of the association between arterial calcification on preoperative imaging and clinical outcomes in peripheral arterial disease","volume":"82","author":"Wiggers","year":"2025","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.10.002_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1358863X251334572","article-title":"Quantification of arterial calcification in peripheral artery disease and its association with amputation and\/or mortality: a systematic review","author":"Woo","year":"2025","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2025.10.002_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","article-title":"Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis","volume":"120","author":"Pastori","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2018.06.041","article-title":"Major adverse limb events and 1-year outcomes after peripheral artery revascularization","volume":"72","author":"Hess","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2025.10.002_bib36","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jvir.2023.07.023","article-title":"Endovascular therapy with interwoven nitinol stent placement after predilation for heavily calcified femoropopliteal artery disease: results of the BURDOCK study","volume":"34","author":"Fujihara","year":"2023","journal-title":"J Vasc Interv Radiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425010019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425010019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:15:09Z","timestamp":1776467709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588425010019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1078588425010019"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.10.002","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endovascular Treatment for Calcified Femoropopliteal Peripheral Artery Disease and Risk Factor Identification: Two Year Outcomes of the Evolusion Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Vascular Surgery. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}